NetworkNewsBreaks

MondayNov 09, 2020 11:23 am

NetworkNewsBreaks – KBL Merger Corp. IV (NASDAQ: KBLM) Completes 180 Life Sciences Corp. Acquisition, to Commence Trading Under Ticker ‘ATNF’ Starting Nov. 9, 2020

KBL Merger Corp. (NASDAQ: KBLM, KBLMR, KBLMW), a special purpose acquisition company (“SPAC”), on Friday announced that a special meeting of shareholders was held on Nov. 5, 2020, where all proposals were approved, including the business combination with 180 Life Sciences Corp. In addition, today KBL Merger Corp. announced successful completion of its acquisition of 180 Life Sciences Corp., a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain. Prior to the closing of the merger, 180 Life Sciences Corp. changed its…

Continue Reading

MondayNov 09, 2020 10:14 am

NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Q2 2021 Financial Results

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today released its unaudited condensed interim consolidated financial statements and management's discussion and analysis (“MD&A”) for the three and six months ended September 30, 2020 (“Q2 2021”). “Our quarter was framed with a sharp focus on PharmHouse. We provided debtor-in-possession financing to enable PharmHouse to remain operational as it commenced its CCAA process and our team has been working towards securing the best possible outcome for our shareholders,” said Narbe Alexandrian, president and CEO of Canopy Rivers. “While supporting PharmHouse has been our priority, we are confident…

Continue Reading

MondayNov 09, 2020 10:00 am

NetworkNewsBreaks – Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF) Implements ‘Venue Bubble’ – First-Ever End-to-End COVID-19 Venue Solution in Live Environment

Loop Insights (TSX.V: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick-and-mortar space, announced the implementation its “Venue Bubble.” According to the update, the fully integrated contact tracing to rapid testing solution was implemented in a live venue environment at the Gulf Coast Showcase in Florida hosting 14 NCAA college basketball teams. The implementation represents the first-ever end-to-end COVID-19 venue solution in a live environment and a significant milestone for Loop Insights. “Today's announcement establishes Loop as a global force in COVID-19 venue…

Continue Reading

MondayNov 09, 2020 9:45 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Unveil Adaptive Design for Berubicin Phase 2 Clinical Trial in Nov. 12 Webinar

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced its plans to issue a video update at 4:30 p.m. ET on Nov. 12, 2020, to discuss the clinical trial design for its upcoming Phase 2 U.S. trial for Berubicin. CNSP’s lead drug candidate – Berubicin – is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive form of brain cancer, currently considered incurable. Robert LeBoyer, managing director of equity research at Ladenburg Thalmann & Co. Inc., will moderate the discussion.…

Continue Reading

FridayNov 06, 2020 12:24 pm

NetworkNewsBreaks – Microsoft Corporation (NASDAQ: MSFT) Featured in Analysis Report

Microsoft (NASDAQ: MSFT), an American multinational technology company with a mission to empower individuals and organizations, was featured in a recent analysis report that discussed soaring consumer demand for MSFT Xbox products. The report, written by LikeFolio Founder Andy Swan, reads, “In the meantime, another key segment caught our attention: gaming. Xbox Series X and Series S preorders began Sept. 22 and demand mentions soared. It was the largest purchase intent spike for the brand we've ever recorded. Tweets showed pre-order sellout in seconds. Consoles arrive Nov. 10. . . just in time for the holiday shopping. Xbox is only…

Continue Reading

FridayNov 06, 2020 12:02 pm

NetworkNewsBreaks – Lululemon Athletica Inc. (NASDAQ: LULU) Featured in Analysis Report

Lululemon (NASDAQ: LULU), a healthy lifestyle inspired athletic apparel company, was featured in a recent analysis report that discussed its consumer demand leading into the holiday season. The report, written by LikeFolio Founder Andy Swan, reads, “We won't lie, we were shocked to see athleisure-darling Lululemon launch a ‘We Made Too Much’ section on its website, full of markdowns for more than 480 products. But then we took a look at LikeFolio data, and it made much more sense. That shaded 20Q3 bar on the far right ends Nov. 1. . . and it's currently pacing -29% QoQ and -24%…

Continue Reading

FridayNov 06, 2020 11:41 am

NetworkNewsBreaks – Intel Corporation (NASDAQ: INTC) Featured in Analysis Report

Intel (NASDAQ: INTC), the world's largest and highest-valued semiconductor chip manufacturer, was featured in a recent analysis report that discussed its performance. The report, written by LikeFolio Founder Andy Swan, reads, “Last quarter, Intel beat revenue and EPS estimates but was dinged on weaker than expected guidance and a delayed timeline for its release of 7-nm chips. LikeFolio data shows consumer buzz is building for Intel's product suite, increasing 13% YoY in 20Q3 and holding volume into the current quarter. This tells us that Intel appears to be making moves in a positive direction from the consumer perspective. What this…

Continue Reading

FridayNov 06, 2020 11:17 am

NetworkNewsBreaks – CYBIN Inc. Completes Reverse Takeover Transaction

CYBIN (formerly Clarmin Explorations Inc.), a life sciences company initially focused on psychedelic pharmaceutical therapies, on Thursday announced it has completed its previously disclosed reverse takeover of Clarmin Explorations Inc. per the terms of an amalgamation agreement dated June 26, 2020, as amended on October 21, 2020. The agreement was among Cybin Corp., Clarmin and 2762898 Ontario Inc. (“SubCo”), a wholly-owned subsidiary of the company (the “reverse takeover”), in which the reverse takeover was completed by way of a “three-cornered” amalgamation pursuant to the provisions of the Business Corporations Act (Ontario). Through the reverse takeover, Cybin Corp. amalgamated with SubCo…

Continue Reading

FridayNov 06, 2020 10:21 am

NetworkNewsBreaks – Josemaria Resources Inc. (TSX: JOSE) (OTC: JOSMF) Files Technical Report for Argentina Copper-Gold Project

Josemaria Resources (TSX: JOSE) (OTC: JOSMF) on Thursday announced that it has filed a technical report prepared under National Instrument 43-101 Standards for Disclosure for Mineral Projects. The report is regarding the company's 100% owned Josemaria Copper-Gold Project, located in San Juan Province, Argentina. The technical report is being filed in support of the information contained in the company's news release dated October 19, 2020, entitled "Josemaria Resources Announces Positive Feasibility Study Showcasing a Conventional, Robust and Rapid Pay Back, Open Pit Copper-Gold Project," as well as in Josemaria's Material Change Report dated October 21, 2020. To view the full…

Continue Reading

FridayNov 06, 2020 9:17 am

NetworkNewsBreaks – Turning Point Therapeutics Inc. (NASDAQ: TPTX) Secures $460M in Underwritten Public Offering

Turning Point Therapeutics (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, has closed an underwritten public offering of 5,287,357 shares of its common stock, including 689,655 additional shares per the full exercise of the over-allotment option granted to the underwriters. According to the update, Turning Point Therapeutics secured approximately $460 million in gross proceeds, with each of the shares sold at the public offering price of $87.00. Roth Capital Partners acted as co-manager for the offering. For more information, visit the company’s website at: www.TPTherapeutics.com About Turning Point Therapeutics Turning Point is a…

Continue Reading